On the 12th Edition of Global Patient Week Bristol Myers Squibb and Saudi Schizophrenia Association 'Ehtiwaa' Collaborate to Support People Living with Schizophrenia Through the 'Small Wins' Initiative
Article excerpt
Highlighted: the sentence this signal was extracted from
More than 70 personalized 'Small Wins' toolkits, assembled by Bristol Myers Squibb employees, were designed to encourage everyday engagement, self-recognition and emotional well-being among people living with schizophrenia in Saudi Arabia. RIYADH, Saudi Arabia, Oct. 12, 2026 /PRNewswire/ -- Reinforcing its commitment to putting patients at the centre of everything it does, Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, recently celebrated the 12th edition of its annual Global Patient Week in the Kingdom of Saudi Arabia. As part of this year's activities, BMS joined forces with the Saudi Schizophrenia Association ('Ehtiwaa') to support individuals living with schizophrenia through a practical, hands-on wellness initiative: the 'Small Wins: Everyday Activity & Motivation' toolkit, designed to boost daily engagement and self-esteem. Schizophrenia is a long-term mental health disorder that can affect the way individuals think, feel and interact with the world around them. These challenges can make activities and routines feel particularly daunting, which makes supportive tools and community initiatives an important part of holistic care and well-being. A Simple Tool for Everyday Empowerment The Small Wins kit offers patients an accessible framework to foster motivation, daily engagement, and self-worth at their own pace. By guiding patients through four...
Keep reading with a free account
The rest of this article, and every signal for Bristol Myers Squibb, is in your free account.
